Begin main content

Call for Patient Input: infliximab

Published on: August 4, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.


Brand name Generic name Manufacturer Indication(s)
TBC infliximab Merck Canada Inc. rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, pediatric ulcerative colitis, psoriatic arthritis, plaque psoriasis
Project Number Call for patient input Patient input deadline Submit patient input
SE0532-000 2017-08-04 2017-09-26 Submit